The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Worthington Mark since 2022.
This trader's CIK number is 1861464.
At the time of last reporting, Worthington Mark was the General Counsel and CCO of Athira Pharma, Inc.. (stock ticker symbol ATHA).
Also see all insider trading activities at Athira Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ATHA | 0 | $0 | 8,526 | $2,506 | 36,666 | $0 |
| 2024 | ATHA | 0 | $0 | 2,525 | $1,429 | 0 | $0 |
| 2022 | ATHA | 0 | $0 | 2,614 | $7,031 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-01 | ATHA | Sale | 8,526 | .29 | 2,506 |
| 2025-06-30 | ATHA | Option Ex | 36,666 | .00 | 0 |
| 2024-09-05 | ATHA | Sale | 2,525 | .57 | 1,429 |
| 2022-06-23 | ATHA | Sale | 2,614 | 2.69 | 7,031 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Worthington Mark (General Counsel and CCO of Athira Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.